Analyst Ratings for Ambrx Biopharma (AMAM)

AMAM Rating Summary

  |   Expand Research on AMAM
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/16/2024 Baird Joel Beatty Downgrade Neutral
(Outperform)		 28.00
(22.00)		 27.97
(28.00)		 0.11% Details
1/10/2024 Citizens Reni Benjamin Downgrade Market Perform
(Market Outperform)		 N/A
(N/A)		 27.47
(28.00)		 1.93% Details